Lab Test's Sensitivity Can Be Advanced With Breakthrough

Breakthrough in nanotechnology will enable better lab test's sensitivity by over three-million-fold, hugely improving early detection of cancer, Alzheimer's disease and other disorders, states study.

Breakthrough in nanotechnology will enable enhancing a lab test's sensitivity over three-million-fold, hugely improving early detection of cancer, Alzheimer's disease and other disorders, reveals study.

It involves a common biological test called an immunoassay, which mimics the action of the immune system to detect the presence of biomarkers - the chemicals linked with diseases.

Importance of Health Screening Tests
Health screening, along with a healthy diet and exercise, is necessary for good health and a higher quality of life.

It would enable doctors to detect the lowest ever concentrations of telltale markers than was previously practical, the journals Nanotechnology and Analytical Chemistry reported.

Simply stated, the immunoassay would require three million times fewer biomarkers to be present compared to an existing conventional immunoassay.

"This advance opens many new and exciting opportunities for immunoassays and other detectors, as well as in disease early detection and treatment," said Stephen Chou, professor of engineering at Princeton, who led the research team.

Alzheimer’s disease - Causes, Symptoms, Diagnosis, Stages, Types, Prevention, Prognosis & Treatment
Alzheimer's disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.

"Furthermore, the new assay is very easy to use, since for the person conducting the test, there will be no difference from the old one - they do the procedure in exactly the same way," added Chou, according to a university statement.

When biomarkers are present in samples, such as those taken from humans, the immunoassay test produces a fluorescent glow (light) that can be measured in a lab. The greater the glow, the more of the biomarker is present.

Autoimmune Disorders - Types - Symptoms - Signs - Diagnosis - Treatment
Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks it.

However, if the amount of biomarker is too small, the fluorescent light is too faint to be detected, setting the limit of detection.

Princeton University researchers tackled this limitation by using nanotechnology to greatly amplify the faint fluorescence from a sample.

A booster for immune systems: unhygienic environs?
A recent comparative study into the lives of wild and laboratory rodents seems to throw light on the aspect of building stronger immune systems when exposed to germs in the environment

By fashioning glass and gold structures so small they could only be seen with a powerful electron microscope, scientists were able to drastically increase the fluorescence signal compared to conventional immunoassays, leading to a three-million-fold improvement in the limit of detection.

That is, the enhanced immunoassay would require three million times fewer biomarkers to be present compared to a conventional immunoassay.

Source-IANS